Experimental evolution of cefiderocol resistance in Pseudomonas aeruginosa
Cefiderocol is a novel and promising cephalosporin approved for treating severe infections caused by Gram-negative bacteria with limited therapeutic options. One of the primary targets of cefiderocol is Pseudomonas aeruginosa, a significant opportunistic Gram-negative pathogen. In this study, we uti...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Articolo |
| Lingua: | inglese |
| Pubblicazione: |
Elsevier
2025-08-01
|
| Serie: | Heliyon |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2405844025020675 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Lascia un commento!